Over 100K Tests at Home - GeneSight Is Empowering Clinicians to Remotely Deliver PGx Testing
President, Myriad Genetics
Mark is president of Myriad Neuroscience.
Mark leads the Myriad Neuroscience team in its quest to improve patients' lives through advanced genetic science.
Named president in 2018, Mark was previously senior vice president, chief sales and business development officer for the company. Prior to joining Myriad, Mark held leadership roles for nearly two decades in the healthcare diagnostics and device industries with Forest Laboratories and Cyberonics.
Mark earned a B.S. in life sciences with a minor in physiology from The Pennsylvania State University
Anna Marie DiPietro, MSN, CRNP, PMHNP-BC, is a Board-Certified Family Psychiatric Mental Health Nurse Practitioner. She conducts psychiatric evaluations, medication management, and GeneSight testing. Anna Marie founded Open Road Psychiatric Services in 2015 in West Chester, PA.
Anna Marie received her training in psychiatry and advanced practice nursing from the University of Pennsylvania School of Nursing. Anna Marie specializes in the field of adult and pediatric psychiatry (ages 5+) with a focus on the treatment of ADHD, mood disorders, anxiety disorders, Autism Spectrum Disorder, Intellectual Disabilities, substance use, psychotic disorders, personality disorders and other psychiatric diagnoses.
Ann Marie has experience in the pediatric, adolescent and adult populations in various treatment settings, including outpatient, inpatient, acute partial programs, residential, and crisis intervention. She has training and experience in diverse therapeutic modalities but has focused much of her career on Applied Behavior Analysis (ABA), Cognitive Behavior Therapy (CBT), and solution-focused therapy. Anna Marieâ€™s research interests include reducing polypharmacy and she has presented on the topic at state, regional, national, and international conferences. Anna Marie enjoys educating patients, their families, clinicians, and other prescribers on psychopharmacology and pharmacogenomics. She values conservative, but effective, medication management paired with thorough evaluation and rapport building with her clients. She has a strong patient focus and is known as being an advocate for those whom she serves.
Join thousands of health plan executives, providers, investors, employers, technologists, and other digital health enthusiasts as we support AFSP to achieve its goal of reducing the annual suicide rate 20% by 2025.